Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AmBisome PK in Liver Transplant Patients
NCT00161356Phase 4Terminated
- Sponsor
- UTHealth Houston
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amphotericin b in fungal infection, sponsored by UTHealth Houston. Primary endpoints: Tissue concentration of AmBisome at 3 months, Bile levels of amphotericin B at 3 weeks and 1 more. Started Sep 2005; status: terminated.
02
Drugs
amphotericin b
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00161356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161356.